<VariationArchive VariationID="52974" VariationName="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs)" VariationType="Duplication" Accession="VCV000052974" Version="35" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2017-12-19" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="67642" VariationID="52974">
      <GeneList>
        <Gene Symbol="KCNQ1" FullName="potassium voltage-gated channel subfamily Q member 1" GeneID="3784" HGNC_ID="HGNC:6294" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.5-15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2445008" stop="2849105" display_start="2445008" display_stop="2849105" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187585.1" start="1031" stop="81270" display_start="1031" display_stop="81270" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2466220" stop="2870339" display_start="2466220" display_stop="2870339" Strand="+" />
          </Location>
          <OMIM>607542</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs)</Name>
      <CanonicalSPDI>NC_000011.10:2588718:AAAAAAAA:AAAAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2588718" stop="2588719" display_start="2588718" display_stop="2588719" variantLength="1" positionVCF="2588718" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2609948" stop="2609949" display_start="2609948" display_stop="2609949" variantLength="1" positionVCF="2609948" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>F296fs</ProteinChange>
      <ProteinChange>F423fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.2" sequenceAccession="NM_000218" sequenceVersion="2" change="c.1265dupA">
            <Expression>NM_000218.2:c.1265dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.3" sequenceAccession="NM_000218" sequenceVersion="3" change="c.1265dupA" MANESelect="true">
            <Expression>NM_000218.3:c.1265dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.2588726dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.2588726dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.2609956dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.2609956dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008935.1" sequenceAccession="NG_008935" sequenceVersion="1" change="g.148736dup">
            <Expression>NG_008935.1:g.148736dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.3" sequenceAccession="NM_000218" sequenceVersion="3" change="c.1265dup" MANESelect="true">
            <Expression>NM_000218.3:c.1265dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000209.2" sequenceAccession="NP_000209" sequenceVersion="2" change="p.Phe423fs">
            <Expression>NP_000209.2:p.Phe423fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406836.1" sequenceAccession="NM_001406836" sequenceVersion="1" change="c.1169dup">
            <Expression>NM_001406836.1:c.1169dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393765.1" sequenceAccession="NP_001393765" sequenceVersion="1" change="p.Phe391Valfs">
            <Expression>NP_001393765.1:p.Phe391Valfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406837.1" sequenceAccession="NM_001406837" sequenceVersion="1" change="c.995dup">
            <Expression>NM_001406837.1:c.995dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393766.1" sequenceAccession="NP_001393766" sequenceVersion="1" change="p.Phe333Valfs">
            <Expression>NP_001393766.1:p.Phe333Valfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406838.1" sequenceAccession="NM_001406838" sequenceVersion="1" change="c.725dup">
            <Expression>NM_001406838.1:c.725dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393767.1" sequenceAccession="NP_001393767" sequenceVersion="1" change="p.Phe243Valfs">
            <Expression>NP_001393767.1:p.Phe243Valfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181798.2" sequenceAccession="NM_181798" sequenceVersion="2" change="c.884dup">
            <Expression>NM_181798.2:c.884dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861463.1" sequenceAccession="NP_861463" sequenceVersion="1" change="p.Phe296Valfs">
            <Expression>NP_861463.1:p.Phe296Valfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040711.2" sequenceAccession="NR_040711" sequenceVersion="2" change="n.1158dup">
            <Expression>NR_040711.2:n.1158dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_287" sequenceAccession="LRG_287">
            <Expression>LRG_287:g.148736dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t1" sequenceAccession="LRG_287t1">
            <Expression>LRG_287t1:c.1265dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p1" sequenceAccession="LRG_287p1" change="p.Phe423Valfs">
            <Expression>LRG_287p1:p.Phe423Valfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t2" sequenceAccession="LRG_287t2">
            <Expression>LRG_287t2:c.884dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p2" sequenceAccession="LRG_287p2" change="p.Phe296fs">
            <Expression>LRG_287p2:p.Phe296fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA005547" DB="ClinGen" />
        <XRef Type="rs" ID="397508083" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND not provided" Accession="RCV000523754" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-23" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND Ear malformation" Accession="RCV001814030" Version="4">
        <ClassifiedConditionList TraitSetID="8298">
          <ClassifiedCondition DB="MedGen" ID="C0266589">Ear malformation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND Jervell and Lange-Nielsen syndrome" Accession="RCV003318348" Version="3">
        <ClassifiedConditionList TraitSetID="25612">
          <ClassifiedCondition DB="MedGen" ID="C0022387">Jervell and Lange-Nielsen syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND Cardiovascular phenotype" Accession="RCV002444507" Version="3">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND multiple conditions" Accession="RCV002477153" Version="2">
        <ClassifiedConditionList TraitSetID="10474">
          <ClassifiedCondition DB="MedGen" ID="C1837014">Atrial fibrillation, familial, 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0004903">Beckwith-Wiedemann syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551509">Jervell and Lange-Nielsen syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551647">Long QT syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865019">Short QT syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND Long QT syndrome 1" Accession="RCV003227628" Version="3">
        <ClassifiedConditionList TraitSetID="797">
          <ClassifiedCondition DB="MedGen" ID="C4551647">Long QT syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1265dup (p.Phe423fs) AND Long QT syndrome" Accession="RCV003531942" Version="2">
        <ClassifiedConditionList TraitSetID="8775">
          <ClassifiedCondition DB="MedGen" ID="C0023976">Long QT syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-08" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2017-12-19" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14998624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15840476</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19862833</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34860437</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9323054</ID>
        </Citation>
        <DescriptionHistory Dated="2022-01-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-19">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10474" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
                <XRef ID="Long+QT+syndrome+1/4297" DB="Genetic Alliance" />
                <XRef ID="MONDO:0100316" DB="MONDO" />
                <XRef ID="MONDO:0008646" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1</ElementValue>
                <XRef ID="GTR000558497" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3284" />
                <XRef ID="3284" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C4551647" DB="MedGen" />
              <XRef ID="MONDO:0100316" DB="MONDO" />
              <XRef Type="MIM" ID="192500" DB="OMIM" />
            </Trait>
            <Trait ID="562" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atrial fibrillation, familial, 3</ElementValue>
                <XRef ID="Atrial+fibrillation%2C+familial%2C+3/7734" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011857" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATFB3</ElementValue>
                <XRef Type="MIM" ID="607554" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15414" />
                <XRef ID="15414" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng196</URL>
                <CitationText>UK NICE Guideline NG196, Atrial fibrillation: diagnosis and management, 2021</CitationText>
              </Citation>
              <XRef ID="C1837014" DB="MedGen" />
              <XRef ID="MONDO:0011857" DB="MONDO" />
              <XRef Type="MIM" ID="607554" DB="OMIM" />
            </Trait>
            <Trait ID="5349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, congenital, and functional heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Prolonged QT interval in EKG and sudden death</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioauditory syndrome of Jervell and Lange-Nielsen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Surdo-cardiac syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
                <XRef ID="MONDO:0024540" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS1</ElementValue>
                <XRef Type="MIM" ID="220400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Jervell and Lange-Nielsen Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C4551509" DB="MedGen" />
              <XRef ID="MONDO:0024540" DB="MONDO" />
              <XRef Type="MIM" ID="220400" DB="OMIM" />
            </Trait>
            <Trait ID="589" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
                <XRef ID="Beckwith-Wiedemann+Syndrome/774" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007534" DB="MONDO" />
                <XRef ID="81780002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Exomphalos macroglossia gigantism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EMG Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BWS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WBS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which affected individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</Attribute>
                <XRef ID="NBK1394" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3343" />
                <XRef ID="3343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301568</ID>
                <ID Source="BookShelf">NBK1394</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="general" Abbrev="Italian BWS Association, 2016">
                <ID Source="PubMed">26592461</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="116" DB="Orphanet" />
              <XRef ID="C0004903" DB="MedGen" />
              <XRef ID="MONDO:0007534" DB="MONDO" />
              <XRef Type="MIM" ID="130650" DB="OMIM" />
            </Trait>
            <Trait ID="5908" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 2</ElementValue>
                <XRef ID="MONDO:0012313" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT2</ElementValue>
                <XRef Type="MIM" ID="609621" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18634" />
                <XRef ID="18634" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865019" DB="MedGen" />
              <XRef ID="MONDO:0012313" DB="MONDO" />
              <XRef Type="MIM" ID="609621" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25612" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34624" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome</ElementValue>
                <XRef ID="MONDO:0002441" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS220400" DB="OMIM" />
                <XRef ID="373905003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Jervell-Lange Nielsen syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3048" />
                <XRef ID="3048" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C0022387" DB="MedGen" />
              <XRef ID="MONDO:0002441" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS220400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
                <XRef ID="Long+QT+Syndrome/4296" DB="Genetic Alliance" />
                <XRef ID="MONDO:0002442" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
                <XRef ID="9651007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LQT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558315" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520446" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515873" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528497" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591169" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522200" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559512" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520458" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552174" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C0023976" DB="MedGen" />
              <XRef ID="D008133" DB="MeSH" />
              <XRef ID="MONDO:0002442" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
                <XRef ID="Long+QT+syndrome+1/4297" DB="Genetic Alliance" />
                <XRef ID="MONDO:0100316" DB="MONDO" />
                <XRef ID="MONDO:0008646" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1</ElementValue>
                <XRef ID="GTR000558497" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3284" />
                <XRef ID="3284" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C4551647" DB="MedGen" />
              <XRef ID="MONDO:0100316" DB="MONDO" />
              <XRef Type="MIM" ID="192500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8298" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="1575" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CUP EAR</ElementValue>
                <XRef Type="MIM" ID="128600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ear malformation</ElementValue>
                <XRef ID="MONDO:0007500" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Abnormality of the ear</ElementValue>
                <XRef ID="HP:0000598" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0266589" DB="MedGen" />
              <XRef ID="MONDO:0007500" DB="MONDO" />
              <XRef Type="MIM" ID="128600" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000598" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3453213" SubmissionDate="2021-09-09" DateLastUpdated="2022-01-22" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="9705451|HPO:HP:0000598" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001755330" DateUpdated="2022-01-22" DateCreated="2022-01-22" Type="SCV" Version="1" SubmitterName="Kariminejad - Najmabadi Pathology &amp; Genetics Center" OrgID="506221" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.3:c.1265dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0000598" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10350875</SubmissionName>
          <SubmissionName>SUB9989790</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5429681" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000218.2:c.1265dup|OMIM:130650;192500;192500;220400;607554;609621" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002783626" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1265dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="130650" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220400" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607554" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609621" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1203641" SubmissionDate="2022-06-01" DateLastUpdated="2023-03-04" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:229322" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617233" DateUpdated="2023-03-04" DateCreated="2017-12-19" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Reported in association with Long QT syndrome (Lupoglazoff et al., 2004; Tester et al., 2005); Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 19862833, 15840476, 26669661, 14998624)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:641610</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1265dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_109_20220601054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7337142" SubmissionDate="2023-05-01" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="NM_000218.2:c.1265dup" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003925157" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The one nucleotide duplication [c.1265dup p.(Phe423ValfsTer40)] identified in exon 10 (of 16) of KCNQ1 alters the wild-type translational reading frame and is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant as well as an adjacent one nucleotide duplication with the same predicted effect on protein [c.1266dupG p.(Phe423ValfsTer40)] have been reported in individuals affected with long QTsyndrome [PMID:15840476, 24912595]. The c.1265dup variant identified here has been reported in ClinVar database as Pathogenic/Likely Pathogenic[Variation ID: 52974], and is absent from population databases (gnomADv2, gnomADv3, TOPMed Freeze 8) suggesting it is not a common benign variant inpopulations represented in those databases. Based on the available evidence, the c.1265dup p.(Phe423ValfsTer40) variant identified in the KCNQ1 gene is reported as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/hhfhf6ms/nygc_assertion_criteria_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001657" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1265dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13087046</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5167343" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a52989|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002679960" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14998624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15840476</ID>
          </Citation>
          <Comment>The c.1265dupA pathogenic mutation, located in coding exon 10 of the KCNQ1 gene, results from a duplication of A at nucleotide position 1265, causing a translational frameshift with a predicted alternate stop codon (p.F423Vfs*40). This mutation (also referred to as g.1258 ins A and ins A 1265&amp;ndash;1266) has been reported in association with long QT syndrome (Tester DJ et al. Heart Rhythm, 2005 May;2:507-17; Lupoglazoff JM et al. J Am Coll Cardiol, 2004 Mar;43:826-30). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1265dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5042158" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_000218.3:c.1265dup|OMIM:192500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002578957" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="397508084" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.3:c.1265dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS4_SUP, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7525381" SubmissionDate="2024-01-08" DateLastUpdated="2024-01-26" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_000218.3:c.1265dup|Jervell and Lange Nielsen syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004022031" DateUpdated="2024-01-26" DateCreated="2023-07-29" Type="SCV" Version="2" SubmitterName="Dept of Medical Biology, Uskudar University" OrgID="508813" OrganizationCategory="other" OrgAbbreviation="UU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria: PVS1_Strong, PS4_Moderate, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Dept of Medical Biology Variant Classification</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/azmpywta/assertion_criteria.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Ethnicity>Turkish</Ethnicity>
              <GeographicOrigin>Turkey</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000218.3:exon 10</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="397508083" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.3:c.1265dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Jervell and Lange Nielsen syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13704591</SubmissionName>
          <SubmissionName>SUB14116911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7980749" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4889554|MedGen:C0023976" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004294079" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9323054</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19862833</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15840476</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34860437</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe423Valfs*40) in the KCNQ1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ1 are known to be pathogenic (PMID: 9323054, 19862833). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Long QT syndrome (PMID: 15840476, 34860437). This variant is also known as ins A 1265‚Äì1266, K422fs/39*. ClinVar contains an entry for this variant (Variation ID: 52974). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2609948_2609949insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023976" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3453213" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000598" MappingRef="HP">
        <MedGen CUI="C0266589" Name="Ear malformation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5042158" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7525381" TraitType="Disease" MappingType="Name" MappingValue="Jervell and Lange Nielsen syndrome" MappingRef="Preferred">
        <MedGen CUI="C0022387" Name="Jervell and Lange-Nielsen syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429681" TraitType="Disease" MappingType="XRef" MappingValue="130650" MappingRef="OMIM">
        <MedGen CUI="C0004903" Name="Beckwith-Wiedemann syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5167343" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429681" TraitType="Disease" MappingType="XRef" MappingValue="220400" MappingRef="OMIM">
        <MedGen CUI="C4551509" Name="Jervell and Lange-Nielsen syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1203641" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429681" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7337142" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001657" MappingRef="HP">
        <MedGen CUI="C0151878" Name="Prolonged QT interval" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429681" TraitType="Disease" MappingType="XRef" MappingValue="609621" MappingRef="OMIM">
        <MedGen CUI="C1865019" Name="Short QT syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7980749" TraitType="Disease" MappingType="XRef" MappingValue="C0023976" MappingRef="MedGen">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429681" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429681" TraitType="Disease" MappingType="XRef" MappingValue="607554" MappingRef="OMIM">
        <MedGen CUI="C1837014" Name="Atrial fibrillation, familial, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7337142" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2017-12-11">SCV000073991</Accession>
        <Description>this interpretation was deleted because it was generated with an out-of-date curation method; no clinical information is available to provide a full interpretation of the variant</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

